Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q2 2023 Earnings

4MayConfirmed

Q3 2022

Q4 2022

Q1 2023

Q2 2023

-14.36

-11.9

-9.44

-6.98

Details

Expected EPS

-8.918854

Actual EPS

-6.975639999999999

Surprise EPS

1.94

Surprise Percent

+21.79%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -6.975639999999999 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.